SEARCH
YOUR SEARCH FOR Text 110 RESULTS
21 of Total
Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs |
… Company’s clinical development portfolio. "The double-digit revenue growth in the first quarter … the potential of povorcitinib as a multibillion-dollar product addressing patient needs across …
Read More
22 of Total
Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs |
… for tafasitamab in combination with lenalidomide for the treatment of adults with relapsed … of tafasitamab in combination with lenalidomide, followed by tafasitamab monotherapy, for …
Read More
23 of Total
0000879169-23-000008 | 10-K | Incyte
… Reports SEC Filings SEC Filing Details Document Details Form 10-K Filing Date Feb 7, 2023 Document Date Dec 31, 2022 Form Description …
Read More
24 of Total
0000879169-24-000045 | 10-K | Incyte
… Reports SEC Filings SEC Filing Details Document Details Form 10-K Filing Date Feb 13, 2024 Document Date Dec 31, 2023 Form Description …
Read More
25 of Total
0001628280-25-004633 | 10-K | Incyte
… Reports SEC Filings SEC Filing Details Document Details Form 10-K Filing Date Feb 10, 2025 Document Date Dec 31, 2024 Form Description …
Read More
26 of Total
0000879169-22-000010 | 10-Q | Incyte
… Reports SEC Filings SEC Filing Details Document Details Form 10-Q Filing Date Nov 1, 2022 Document Date Sep 30, 2022 Form Description …
Read More
27 of Total
0000879169-23-000016 | 10-Q | Incyte
… Reports SEC Filings SEC Filing Details Document Details Form 10-Q Filing Date May 2, 2023 Document Date Mar 31, 2023 Form Description …
Read More
28 of Total
0000879169-23-000025 | 10-Q | Incyte
… Reports SEC Filings SEC Filing Details Document Details Form 10-Q Filing Date Aug 1, 2023 Document Date Jun 30, 2023 Form Description …
Read More
29 of Total
0000879169-23-000041 | 10-Q | Incyte
… Reports SEC Filings SEC Filing Details Document Details Form 10-Q Filing Date Oct 31, 2023 Document Date Sep 30, 2023 Form Description …
Read More
30 of Total
0000879169-24-000077 | 10-Q | Incyte
… Reports SEC Filings SEC Filing Details Document Details Form 10-Q Filing Date Apr 30, 2024 Document Date Mar 31, 2024 Form Description …
Read More